42 related articles for article (PubMed ID: 32156458)
1. Site-specific immobilization of Cysteinyl leukotriene receptor 1 through enzymatic DNA-protein conjugation strategy for lead screening.
Wen X; Chen M; Li Z; Liu W; Xu K; Wang J; Zhao X
J Chromatogr A; 2024 Jul; 1727():464948. PubMed ID: 38759460
[TBL] [Abstract][Full Text] [Related]
2. On the Rational Drug Design for Hypertension through NMR Spectroscopy.
Chontzopoulou E; Tzakos AG; Mavromoustakos T
Molecules; 2020 Dec; 26(1):. PubMed ID: 33375119
[TBL] [Abstract][Full Text] [Related]
3. Multiple protein stationary phases: a review.
Singh NS; Habicht KL; Dossou KS; Shimmo R; Wainer IW; Moaddel R
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 968():64-8. PubMed ID: 24780640
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Supramolecular Affinity Separations: Affinity Chromatography and Related Methods.
Woolfork AG; Iftekhar S; Ovbude S; Suh K; Sharmeen S; Kyei I; Jones J; Hage DS
Adv Chromatogr; 2021; 58():1-74. PubMed ID: 36186535
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of immobilized 5-HT
Chen YY; Jin YH; Shayiranbieke A; Zhao X; Fan HS; Li Q; Zhao XF
J Pharm Biomed Anal; 2022 Mar; 211():114632. PubMed ID: 35131672
[TBL] [Abstract][Full Text] [Related]
6. [Advances in chromatography in the study of drug-plasma protein interactions].
Bai Y; Fan Y; Ge G; Wang F
Se Pu; 2021 Oct; 39(10):1077-1085. PubMed ID: 34505429
[TBL] [Abstract][Full Text] [Related]
7. Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.
Takezako T; Unal H; Karnik SS; Node K
Pharmacol Res; 2017 Sep; 123():40-50. PubMed ID: 28648738
[TBL] [Abstract][Full Text] [Related]
8. Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?
Unger T
Am J Cardiol; 1999 Nov; 84(10A):9S-15S. PubMed ID: 10588089
[TBL] [Abstract][Full Text] [Related]
9. Immobilized angiotensin II type I receptor: A powerful method of high throughput screening for antihypertensive compound identification through binding interaction analysis.
Liang Q; Fu X; Zhang J; Hao J; Feng G; Wang J; Li Q; Ahmad F; Zhao X
J Chromatogr A; 2020 Jun; 1620():461003. PubMed ID: 32156458
[TBL] [Abstract][Full Text] [Related]
10. Identification of selective ligands targeting two GPCRs by receptor-affinity chromatography coupled with high-throughput sequencing techniques.
Liang Q; Zhao X; Fu X; Wang J; Li Q; Zhao X
Bioorg Chem; 2021 Jul; 112():104986. PubMed ID: 34029972
[TBL] [Abstract][Full Text] [Related]
11. Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan.
Miura S; Okabe A; Matsuo Y; Karnik SS; Saku K
Hypertens Res; 2013 Feb; 36(2):134-9. PubMed ID: 23034464
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.
Le MT; Pugsley MK; Vauquelin G; Van Liefde I
Br J Pharmacol; 2007 Aug; 151(7):952-62. PubMed ID: 17572702
[TBL] [Abstract][Full Text] [Related]
13. A chromatographic method for determining the interaction between a drug and two target proteins by fabricating a dual-heterogeneous surface.
Qu L; Li T; Cun S; Zheng X; Xiang M; Dong Y; Ji X; Bian L; Li Q; Zhao X
J Chromatogr A; 2024 Jan; 1715():464606. PubMed ID: 38154257
[TBL] [Abstract][Full Text] [Related]
14. Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling.
Bhuiyan MA; Ishiguro M; Hossain M; Nakamura T; Ozaki M; Miura S; Nagatomo T
Life Sci; 2009 Jul; 85(3-4):136-40. PubMed ID: 19446572
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
